Ratings by Clear Street (Bill Maughan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/28/2026 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2026 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2026 | Beam Therapeutics Inc | BEAM | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2026 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2026 | Regenxbio Inc. | RGNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Ocular Therapeutix | OCUL | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Delcath Systems | DCTH | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2026 | Korro Bio Inc. | KRRO | Upgrade | Buy (Hold) |
11.48 (12.25) |
6.71% | Details | |
| 2/12/2026 | Century Therapeutics | IPSC | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2026 | Caribou Biosciences Inc. | CRBU | New Coverage | Buy (N/A) |
1.41 (1.65) |
17.02% | Details | |
| 2/2/2026 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | Korro Bio Inc. | KRRO | Maintain | Hold (N/A) |
|
Details | ||
| 1/26/2026 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2026 | Century Therapeutics | IPSC | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2025 | Cellectis | CLLS | New Coverage | Buy (N/A) |
4.37 (2.63) |
-39.82% | Details | |
| 12/8/2025 | BioNTech | BNTX | Maintain | Buy (Buy) |
|
Details | ||
| 12/2/2025 | Annexon Biosciences | ANNX | New Coverage | Buy (N/A) |
4.50 (5.80) |
28.89% | Details | |
| 11/13/2025 | Korro Bio Inc. | KRRO | Downgrade | Hold (Buy) |
32.80 (12.25) |
-62.65% | Details | |
| 11/10/2025 | Editas Medicine | EDIT | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2025 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 11/4/2025 | Beam Therapeutics Inc | BEAM | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2025 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2025 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | Korro Bio Inc. | KRRO | New Coverage | Buy (N/A) |
38.78 (32.80) |
-15.42% | Details | |
| 10/15/2025 | WAVE Life Sciences | WVE | New Coverage | Buy (N/A) |
7.79 (5.82) |
-25.29% | Details | |
| 9/17/2025 | Dianthus Therapeutics | DNTH | New Coverage | Buy (N/A) |
37.04 (105.60) |
185.1% | Details | |
| 9/5/2025 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2025 | Summit Therapeutics plc | SMMT | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Y-mAbs Therapeutics | YMAB | Downgrade | Hold (Buy) |
4.19 (8.61) |
105.49% | Details | |
| 8/5/2025 | Beam Therapeutics Inc | BEAM | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Ocular Therapeutix | OCUL | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2025 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2025 | Krystal Biotech | KRYS | New Coverage | Buy (N/A) |
138.88 (354.86) |
155.52% | Details | |
| 6/30/2025 | Summit Therapeutics plc | SMMT | New Coverage | Buy (N/A) |
20.60 (13.81) |
-32.96% | Details | |
| 6/27/2025 | CRISPR Therapeutics | CRSP | Downgrade | Hold (Buy) |
47.66 (47.78) |
0.25% | Details | |
| 6/2/2025 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2025 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2025 | Ocular Therapeutix | OCUL | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2025 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2025 | Delcath Systems | DCTH | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2025 | CRISPR Therapeutics | CRSP | Upgrade | Buy (Hold) |
33.16 (47.66) |
43.73% | Details | |
| 4/1/2025 | Molecular Partners | MOLN | New Coverage | Buy (N/A) |
4.56 (3.90) |
-14.47% | Details | |
| 4/1/2025 | Beam Therapeutics Inc | BEAM | New Coverage | Buy (N/A) |
22.21 (27.53) |
23.95% | Details | |
| 4/1/2025 | Regenxbio Inc. | RGNX | New Coverage | Buy (N/A) |
7.83 (9.89) |
26.31% | Details | |
| 3/5/2025 | BioNTech | BNTX | New Coverage | Buy (N/A) |
111.56 (91.48) |
-18% | Details | |
| 3/4/2025 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2024 | Ocular Therapeutix | OCUL | New Coverage | Buy (N/A) |
9.02 (8.97) |
-0.55% | Details | |
| 12/19/2024 | Editas Medicine | EDIT | New Coverage | Buy (N/A) |
1.52 (2.98) |
96.05% | Details | |
| 12/18/2024 | CRISPR Therapeutics | CRSP | New Coverage | Hold (N/A) |
44.63 (33.16) |
-25.7% | Details | |
| 12/13/2024 | Century Therapeutics | IPSC | New Coverage | Buy (N/A) |
1.35 (2.25) |
66.67% | Details | |
| 12/13/2024 | Delcath Systems | DCTH | New Coverage | Buy (N/A) |
12.27 (12.81) |
4.4% | Details | |
| 12/12/2024 | Y-mAbs Therapeutics | YMAB | New Coverage | Buy (N/A) |
10.01 (8.61) |
-13.99% | Details |
